Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Champions Oncology (CSBR) Gross Profit (2016 - 2026)

Champions Oncology has reported Gross Profit over the past 17 years, most recently at $13.9 million for Q1 2026.

  • For Q1 2026, Gross Profit rose 33.3% year-over-year to $13.9 million; the TTM value through Jan 2026 reached $38.9 million, down 26.01%, while the annual FY2025 figure was $28.6 million, 33.73% down from the prior year.
  • Gross Profit for Q1 2026 was $13.9 million at Champions Oncology, up from $7.8 million in the prior quarter.
  • Over five years, Gross Profit peaked at $29.1 million in Q2 2024 and troughed at -$6.0 million in Q2 2022.
  • A 5-year average of $8.7 million and a median of $7.0 million in 2024 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: tumbled 165.89% in 2022 and later soared 407.4% in 2024.
  • Year by year, Gross Profit stood at $6.8 million in 2022, then fell by 27.54% to $5.0 million in 2023, then rose by 22.32% to $6.1 million in 2024, then rose by 28.25% to $7.8 million in 2025, then surged by 78.73% to $13.9 million in 2026.
  • Business Quant data shows Gross Profit for CSBR at $13.9 million in Q1 2026, $7.8 million in Q4 2025, and $12.1 million in Q3 2025.